Humanized anti-interleukin-6 receptor (IL-6R) monoclonal antibodies are used in many inflammation-related diseases, such as active rheumatoid arthritis (RA), giant cell arteritis (GCA), cytokine release syndrome (CRS), and coronavirus disease 2019 (COVID-19) [1,2,3]. Here, IL6R is linked to temporal arteritis.